Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

Recruiting

Phase 1

Phase 2

Orca QPhase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

Sponsor:

University of Florida

Code:

NCT05322850

Conditions

Acute Myeloid Leukemia

Acute Lymphoid Leukemia

Mixed Phenotype Acute Leukemia

Acute Undifferentiated Leukemia

Chronic Myeloid Leukemia in Myeloid Blast Crisis

Eligibility Criteria

Sex: All

Age: 0 - 50

Healthy Volunteers: Accepted

Interventions

Orca-Q

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-10. This information was provided to ClinicalTrials.gov by University of Florida on 2025-12-15.